Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Sanofi-Aventis Canada Inc.
02 1Gowling WLG (Canada) LLP
01 32268927
02 12717605
01 2TRIAMCINOLONE ACETONIDE
02 2Triamcinolone Acetonide
01 1Aqueous Nasal Spray
02 1Injectable suspension
03 1LIQUID
04 1SPRAY
01 32017-07-02
02 12029-03-10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2017-07-02
Date Granted : 2003-09-23
Brand Name : NASACORT AQ
Patent Number : 2268927
Filing Date : 1997-07-02
Strength per Unit : 55mcg / dose
Dosage Form : Aqueous Nasal Spray
Human Or VET : Human
Route of Administration : Nasal
Patent Expiration Date : 2017-07-02
Date Granted : 2003-09-23
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2017-07-02
Date Granted : 2003-09-23
Brand Name : NASACORT ALLERGY 24HR
Patent Number : 2268927
Filing Date : 1997-07-02
Strength per Unit : 55 ?g
Dosage Form : LIQUID
Human Or VET : Human
Route of Administration : NASAL
Patent Expiration Date : 2017-07-02
Date Granted : 2003-09-23
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2017-07-02
Date Granted : 2003-09-23
Brand Name : NASACORT ALLERGY 24HR
Patent Number : 2268927
Filing Date : 1997-07-02
Strength per Unit : 55 ?g
Dosage Form : SPRAY
Human Or VET : Human
Route of Administration : NASAL
Patent Expiration Date : 2017-07-02
Date Granted : 2003-09-23
Patent Expiration Date : 2029-03-10
Date Granted : 2012-05-15
Brand Name : TRIESENCE
Patent Number : 2717605
Filing Date : 2009-03-10
Strength per Unit : 40 mg / mL
Dosage Form : Injectable suspension
Human Or VET : Human
Route of Administration : Intravitreal
Patent Expiration Date : 2029-03-10
Date Granted : 2012-05-15
LOOKING FOR A SUPPLIER?